Abstract
ObjectivesTo conduct the benefit–risk assessment of 3-hydroxy-3-methyl-glutaryl (HMG) coenzyme A reductase inhibitors (statins) using a discrete choice experiment, based on 3 major stakeholders’ perspectives including patients, experts and policymakers in...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have